Publication | Closed Access

Duloxetine protects against experimental diabetic retinopathy in mice through retinal GFAP downregulation and modulation of neurotrophic factors

Diabetic RetinopathyOcular DiseaseRetinaOphthalmologyMedicineExperimental Diabetic RetinopathyPhysiologyDiabetesRetinal Gfap DownregulationNeuropharmacologyNeuroprotectionPharmacologyNeurotrophic Factors